 |
|
Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations
Soon Sun Kim, Jae Youn Cheong
Clin Mol Hepatol. 2022;28(4):802-805. Published online 2022 Sep 14 DOI: https://doi.org/10.3350/cmh.2022.0249
|
|
Citations to this article as recorded by
 Correspondence on Editorial regarding “Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations”
Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn
Clinical and Molecular Hepatology.2023; 29(1): 185. CrossRef Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
Hye Won Lee
Clinical and Molecular Hepatology.2023; 29(1): 169. CrossRef
|